AU Patent

AU723351B2 — Method of treating heart failure with endothelin antagonists

Assigned to MSD KK · Expires 2000-08-24 · 26y expired

What this patent protects

A method for preventing and/or treating heart failure and ventricular dysfunction in a warm blooded animal comprising administering to the warm blooded animal a therapeutically effective amount of an endothelin antagonist of the formula: as defined herein.

USPTO Abstract

A method for preventing and/or treating heart failure and ventricular dysfunction in a warm blooded animal comprising administering to the warm blooded animal a therapeutically effective amount of an endothelin antagonist of the formula: as defined herein.

Drugs covered by this patent

Patent Metadata

Patent number: AU723351B2
Jurisdiction: AU
Classification: —
Expires: 2000-08-24
Drug substance claim: No
Drug product claim: No
Assignee: MSD KK
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.